Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Low Grade Glioma — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Neuroepithelial, Perineurial, and Schwann Cell Neoplasm
Neuroepithelial Neoplasm
Glioma
Low Grade Glioma

Subtype

Low Grade Glioma

CI-CAN-00003062LGGExplore in graph →

Non-malignant115 active trials62 evidence items

NCIt: C132067
OncoTree: LGGNOS
DOID: 0080829
Other: 1 more code

Overview
Statistics
Survival
Genomics2
Variants & evidence62
Drugs13
Trials324
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (39)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 26, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 26–39 of 39 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study.
· J Clin Oncol · 2010 · PMID 20713864 · validated civic_curation pubmed
Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent.
· J Transl Med · 2014 · PMID 25524464 · validated civic_curation pubmed
Activity of Pemigatinib in Pilocytic Astrocytoma and FGFR1N546K Mutation.
· JCO Precis Oncol · 2022 · PMID 35507888 · validated civic_curation pubmed
Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients.
· J Neurosurg Spine · 2011 · PMID 21294614 · validated civic_curation pubmed
CDKN2A/B Loss Is Associated with Anaplastic Transformation in a Case of NTRK2 Fusion-positive Pilocytic Astrocytoma.
· Neuropathol Appl Neurobiol · 2019 · PMID 29804288 · validated civic_curation pubmed
Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
· Acta Neuropathol Commun · 2021 · PMID 34389065 · validated civic_curation pubmed
MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas.
· Acta Neuropathol · 2010 · PMID 21046410 · validated civic_curation pubmed

Showing 26–39 of 39 publications

← Previous
1
2
Next →

NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.

· Mod Pathol · 2020 · PMID 31375766 · validated civic_curation pubmed

Supratentorial ependymoma with YAP1:FAM118B fusion: A case report.

· Neuropathology · 2021 · PMID 33480048 · validated civic_curation pubmed

An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.

· Science · 2013 · PMID 23558169 · validated civic_curation pubmed

A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-κB.

· Cell Rep · 2018 · PMID 29949764 · validated civic_curation pubmed

Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.

· Oncotarget · 2017 · PMID 28002790 · validated civic_curation pubmed

Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways.

· Oncotarget · 2017 · PMID 29156677 · validated civic_curation pubmed

Posterior fossa ependymoma H3 K27-mutant: an integrated radiological and histomolecular tumor analysis.

· Acta Neuropathol Commun · 2022 · PMID 36104744 · validated civic_curation pubmed